Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Receivables - Other: 2020-2024

Historic Receivables - Other for Cellebrite DI (CLBT) over the last 5 years, with Dec 2024 value amounting to $81.3 million.

  • Cellebrite DI's Receivables - Other fell 8.78% to $81.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $81.3 million, marking a year-over-year decrease of 8.78%. This contributed to the annual value of $81.3 million for FY2024, which is 8.78% down from last year.
  • As of FY2023, Cellebrite DI's Expense - Property Taxes and Insurance stood at -$345,000.
  • Cellebrite DI's Receivables - Other's 5-year high stood at $89.2 million during FY2023, with a 5-year trough of $33.9 million in FY2020.
  • In the last 1 years, Cellebrite DI's Expense - Property Taxes and Insurance had a median value of -$345,000 in 2023 and averaged -$345,000.
  • In the last 5 years, Cellebrite DI's Receivables - Other surged by 113.13% in 2021 and then decreased by 8.78% in 2024.
  • Over the past 5 years, Cellebrite DI's Receivables - Other (Yearly) stood at $33.9 million in 2020, then surged by 113.13% to $72.3 million in 2021, then rose by 12.83% to $81.5 million in 2022, then increased by 9.38% to $89.2 million in 2023, then fell by 8.78% to $81.3 million in 2024.